FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

2156811000001107: Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25182101000001113 Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
112399301000001118 Zomig 2.5mg tablets (Grunenthal Ltd) 12 tablet 4 x 3 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Is a Zolmitriptan 2.5mg tablets 12 tablet true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Is pack of Zomig 2.5mg tablets (AstraZeneca) false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Has active ingredient Zolmitriptan false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Has AMP Zomig 2.5mg tablets (AstraZeneca) true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Has specific active ingredient Zolmitriptan true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zomig 2.5mg tablets (AstraZeneca) 12 tablet 4 x 3 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start